These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11237494)

  • 1. Pre-clinical study of the epinephrine-cisplatin association for the treatment of intraperitoneal carcinomatosis.
    Favoulet P; Magnin G; Guilland JC; Beltramo JL; Osmak L; Benoit L; Rat P; Douvier S; Duvillard C; Chauffert B
    Eur J Surg Oncol; 2001 Feb; 27(1):59-64. PubMed ID: 11237494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
    Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
    Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat].
    Benoit L; Duvillard C; Beltramo JL; Brunet-Lecomte P; Chauffert B
    Gastroenterol Clin Biol; 2000 Jan; 24(1):26-30. PubMed ID: 10679584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
    Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
    Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epinephrine enhances penetration and anti-cancer activity of local cisplatin on rat sub-cutaneous and peritoneal tumors.
    Duvillard C; Benoit L; Moretto P; Beltramo JL; Brunet-Lecomte P; Correia M; Sergent C; Chauffert B
    Int J Cancer; 1999 May; 81(5):779-84. PubMed ID: 10328233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
    Colombo PE; Boustta M; Poujol S; Pinguet F; Rouanet P; Bressolle F; Vert M
    Eur J Pharm Sci; 2007 May; 31(1):43-52. PubMed ID: 17383164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
    Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
    Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR; Cai GF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
    Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique.
    Oman M; Tölli J; Naredi P; Hafström LO
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):213-8. PubMed ID: 15138707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis.
    Cattel L; De Simone M; Passera R; Verlengo MC; Delprino L
    Anticancer Res; 2004; 24(3b):2041-5. PubMed ID: 15274398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin.
    Gunji S; Obama K; Matsui M; Tabata Y; Sakai Y
    Surgery; 2013 Nov; 154(5):991-9. PubMed ID: 24008088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats.
    Tsujitani S; Oka A; Kondo A; Katano K; Oka S; Saito H; Ikeguchi M; Maeta M; Kaibara N
    Oncology; 1999 Jul; 57(1):77-82. PubMed ID: 10394129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
    Zeamari S; Floot B; van der Vange N; Stewart FA
    Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of intra-abdominal temperature on the tissue and tumor diffusion of intraperitoneal cisplatin in a model of peritoneal carcinomatosis in rats].
    Benoit L; Duvillard C; Rat P; Chauffert B
    Chirurgie; 1999 Sep; 124(4):375-9. PubMed ID: 10546390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].
    Chauffert B; Dimanche-Boitrel MT; Genne P; Petit JM; Onier N; Jeannin JF
    Gastroenterol Clin Biol; 1992; 16(3):215-9. PubMed ID: 1582536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.
    Los G; Mutsaers PH; van der Vijgh WJ; Baldew GS; de Graaf PW; McVie JG
    Cancer Res; 1989 Jun; 49(12):3380-4. PubMed ID: 2720692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.
    Pili-Floury S; Royer B; Bartholin F; Crumiere N; Combe M; Chalopin JM; Pivot X; Heyd B; Chauffert B; Samain E
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):199-203. PubMed ID: 21306815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and antitumoral effect of long-circulating and pH-sensitive liposomal cisplatin administered in Ehrlich tumor-bearing mice.
    Araújo JG; Mota Ld; Leite EA; Maroni Lde C; Wainstein AJ; Coelho LG; Savassi-Rocha PR; Pereira MT; de Carvalho AT; Cardoso VN; De Oliveira MC
    Exp Biol Med (Maywood); 2011 Jul; 236(7):808-15. PubMed ID: 21685237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.